Top 10 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Growth Drivers, Industry Chain Analysis, Technological Improvements and Future Trends to 2023

0

Active Pharmaceutical Ingredient, or API, is basically the component of any prescribed drug that releases its effect on the human body. Every drug developed contains two main components, the API and the excipients, which are the chemically inactive parts of the drug. The development of medical science has led to the creation of high potency APIs which can produce the desired drug result in a much higher capacity.

Market overview

High potency APIs find their use in treating medical cases that go far beyond ordinary remedies. Various tests are performed to determine the API level of a drug, and each pharmaceutical company must report their API levels to the FDA.

The expected valuation of the high power API market stands at 26.6 billion with an expected CAGR of 8.40% over the forecast period 2017 to 2023.

The market is mainly driven by the number of investments made by companies in high power APIs. Contract agencies that provide medical product manufacturing services are growing across the globe and are an extremely cost-effective option for most pharmaceutical brands, thereby driving the growth of the market.

Trends in medical science have also added to the cause. Targeted therapy is one of the latest methods of treating conditions that use high potency APIs. Advancement in the concept of health awareness in developing countries such as India, China and others has also led to the growth of the high potency API market.

Competitive scoreboard of the main players:

Some of the key players profiled in the report are Teva Pharmaceuticals, SAFC, Carbogen Amics, Bristol-Myers Squibb, Asymchem, Lonza, Bayer AG, Boehringer Ingelheim and Sanofi.

Get a FREE sample on: https://www.marketresearchfuture.com/sample_request/6679

Chapter 11. Business Profiles

11.1 Teva Pharmaceuticals

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Finance Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 CFSS

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial overview

11.2.4 Main developments

11.2.5 SWOT Analysis

11.3 Carbon Amics

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bristol-Myers Squibb

11.4.1 Company Overview

11.4.2 Business Segment Overview

…Continued.

Market segmentation

The latest report published by Market Research Future (MRFR) indicates that the High Potency API market is segmented on the basis of therapeutic area, type and product.

By product, the market is divided into biotech and synthetic. Rising demand for Antibody-Drug Conjugates (ADCs) is expected to drive the growth of the biotechnology segment market in the coming years.

By type, the market includes generic and new or innovative products. The market is dominated by the innovative segment. This can be attributed to the availability of huge funds for research and development purposes by the manufacturers.

By therapeutic area, the market includes hormones, oncology, glaucoma and others. Among all the segments, Glaucoma is believed to experience significant growth and demand over the review period.

Get a full and detailed copy of this report on: https://www.marketresearchfuture.com/reports/high-potency-apis-market-6679

Regional analysis

Geographical segmentation of the high power API market covers Europe, Asia-Pacific, Americas, Middle East and Africa.

North America is leading in terms of high power API market growth and is expected to witness substantial growth over the forecast period. The well-established healthcare sector in the region coupled with the widespread prevalence of chronic diseases is expected to drive the expansion of the market in the coming years. There is a large pool of cancer patients located here, thus contributing as another key factor responsible for the growth of the regional market. The region is likely to see an influx of investments, which will drive both innovations and drug developments forward in the market. It is also anticipated that the favorable support given by the government will only boost the growth potential of the high power API market. Other factors that are expected to inversely favor the expansion of the high potency API market are changing consumer lifestyle, old age diseases, increasing number of biotech industries, etc.

About Market Research Future: Our market research by products, services, technologies, applications, end users and market players for market segments at global, regional and country level, enables our clients to see more, know more and do more, which helps answer all their most important questions.

Contact:

Future of Market Research

+1 646 845 9312

Email: [email protected]

Share.

Comments are closed.